Last reviewed · How we verify

NCT03712995

Reconstruction of Upper Eyelid With a Newly Modified Cutler-Beard Technique With Tarsoconjunctival Graf

Completed NA Last updated 10 December 2018
What this trial tests

NA trial testing 'Cutler-Beard modified with graft' in Reconstructive Surgical Procedure in 10 participants. Completed in 31 December 2016.

Timeline
1 January 2011
Primary endpoint
31 December 2016
31 December 2016

Quick facts

Lead sponsorHospital Universitario 12 de Octubre
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment10
Start date1 January 2011
Primary completion31 December 2016
Estimated completion31 December 2016

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Universitario 12 de Octubre

Who can join

Adults 18 to 90, any sex, with Reconstructive Surgical Procedure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To study the results of a modified Cutler-Beard technique , using a contralateral tarsoconjunctival graft, in patients who underwent excision of large malignant tumors of the upper eyelid

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Reconstruction of Upper Eyelid Defects Secondary to Malignant Tumors with a Newly Modified Cutler-Beard Technique with Tarsoconjunctival Graft.
    Bengoa-González Á, Laslău BM, Martín-Clavijo A, Mencía-Gutiérrez E, et al · · 2019 · cited 10× · PMID 30944732 · DOI 10.1155/2019/6838415

Verify or expand the search:

Other recruiting trials for Reconstructive Surgical Procedure

Currently open trials in the same condition.

Other Hospital Universitario 12 de Octubre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03712995.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing